# An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function

> **NCT03515980** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 76 (actual)

## Conditions studied

- Liver Dysfunction
- Liver Insufficiency
- Hepatic Failure
- Myocardial Failure
- Cardiac Failure
- Congestive Heart Failure
- Heart Decompensation

## Interventions

- **DRUG:** BMS-986231

## Key facts

- **NCT ID:** NCT03515980
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-25
- **Primary completion:** 2019-08-29
- **Final completion:** 2019-08-29
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2020-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03515980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03515980, "An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03515980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*